The Misfit “Shine” is a new device that empowers people to track their daily activity goals in a simple and elegant way. Sonny Vu and Sridhar Iyengar, co-founders…
Mary Hesdorffer, NP and Executive Director of the Mesothelioma Applied Research Foundation, discusses the latest advances in treatment options for mesothelioma. Results from early-stage clinical trials show a…
NEW YORK (Reuters Health) – Sorafenib delivered concurrently with transarterial chemoembolization (TACE) is safe in patients with intermediate hepatocellular cancer and does not lead to any unexpected adverse…
NEW YORK (Reuters Health) – As second-line treatment for locally advanced or metastatic non-small-cell lung cancer in Chinese patients, pemetrexed is as effective as docetaxel but with fewer…
Pertussis or whopping cough is a contagious respiratory disease that can be life-threatening to newborns and infants. Children are better protected after receiving a 5-dose vaccine series. A…
NEW YORK (Reuters Health) – Parenteral hydration offers virtually no benefit to hospice patients with advanced cancer. There are no established standards for hydration at the end of…
Using the computer to communicate with your physician, schedule an appointment, see test results and even request prescription refills is becoming an important component of health care reform.…
The legalization of marijuana has been a hot topic of debate over the past few years. Some people further the support the use of marijuana for medicinal purposes.…
NEW YORK (Reuters Health) – While oxybutynin is often used prophylactically to reduce irritative urinary symptoms related to intravesical bacillus Calmette-Guerin (BCG) therapy for bladder cancer, it actually…
NEW YORK (Reuters Health) – In patients with liver cancer related to hepatitis B virus (HBV) infection, giving nucleoside analogues after curative surgery appears to reduce the risk…
